Accurate evaluation of QT interval in conscious rhesus monkeys (Macaca mulatta) by use of Holter ECG

Journal of Electrocardiology

Volumn 35, Issue 4, 2002, Pages 333-342

  Hassimoto, Masatoshi ^a   Harada, Takuma ^a   Kaga, Nobuhiko ^a   Murano, Hiroyuki ^a   Obata, Masaomi ^a  

^a MOCHIDA PHARMACEUTICAL CO   (Japan)

Author keywords

Holter ECG; QT interval; QTc; Rhesus Monkey; RR interval

Indexed keywords

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HEART RATE; HOLTER MONITORING; MACACA; MALE; NONHUMAN; PRIORITY JOURNAL; QT INTERVAL; RR INTERVAL;

EID: 0036804529     PISSN: 00220736     EISSN: None     Source Type: Journal    
DOI: 10.1054/jelc.2002.35846     Document Type: Article

References (25)

1. Lazzara R: Antiarrhythmic drugs and torsade de pointes. Eur Heart J 14(Suppl H):88, 1993
2. Leatham EW, Holt DW, McKenna WJ: Class III antiarrhythmics in overdose. Presenting features and management principles. Drug Saf 9:450, 1993
3. Zehender M, Hohnloser S, Just H: QT-interval prolonging drugs: Mechanisms and clinical relevance of their arrhythmogenic hazards. Cardiovasc Drugs Ther 5:515, 1991
4. Bigger JT, Jr., Sahar DI: Clinical types of proarrhythmic response to antiarrhythmic drugs. Am J Cardiol 59:2E, 1987
5. de Abajo FJ, Rodriguez LA: Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs. Br J Clin Pharmacol 47:307, 1999
6. Hill SL, Evangelista JK, Pizzi AM, et al.: Proarrhythmia associated with cisapride in children. Pediatrics 101:1053, 1998
7. Ohmura T, Chachin M, Tarui S, et al: Effects of terfenadine, astemizole and epinastine on electrocardiogram in conscious cynomolgus monkeys. Eur J Pharmacol 378:169, 1999
8. Metzger E, Friedman R: Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill. J Clin Psychopharmacol 13:128, 1993
9. Woosley RL, Chen Y, Freiman JP, et al: Mechanism of the cardiotoxic actions of terfenadine. Jama 269:1532, 1993
10. Bazett HC: An analysis of the time-relations of electrocardiograms. Heart 7:353, 1920
11. Fridericia LS: Die systolendauer im electrokardiogramm bei normalen menshen und bei herzkranken. Acta Med Scand 53:469, 1920
12. Ashman R: The normal duration of the Q-T interval. Am Heart J 23:522, 1942
13. Hayes E, Pugsley MK, Penz WP, et al: Relationship between QaT and RR intervals in rats, guinea pigs, rabbits, and primates. J Pharmacol Toxicol Methods 32:201, 1994
14. Matsunaga T, Mitsui T, Harada T, et al.: QT corrected for heart rate and relation between QT and RR intervals in beagle dogs. J Pharmacol Toxicol Methods 38:201, 1997
15. Japanese Association for Laboratory Animal Science: Guidelines for animal experimentation. Jikken Dobutsu 36:285, 1987
16. ICH Steering Committee: Guideline on safety pharmacology studies for assessing the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals (S7B). In: ICH Steering Committee Meeting, Brussels, February 2002
17. Akaike H: A new look at the statistical model identification. IEEE Trans Autom Cont 19:716, 1974
18. Schoenwald RD, Isaacs VE: QT corrected for heart rate: A new approach and its application. Arch Int Pharmacodyn Ther 211:34, 1974
19. Lepeschkin E, Surawicz B: The measurement of the Q-T interval of the electrocardiogram. Circulation 6:378, 1952
20. Saikawa T, Tsumabuki S, Nakagawa M, et al: QT intervals as an index of high serum calcium in hypercalcemia. Clin Cardiol 11:75, 1988
21. Emori T, Ohe T, Aihara N, et al: Dynamic relationship between the Q-aT interval and heart rate in patients with long QT syndrome during 24-hour Holter ECG monitoring. Pacing Clin Electrophysiol 18:1909, 1995
22. ICH Steering Committee: Guideline on Safety Pharmacology Studies for Human Pharmaceuticals (57A). In: ICH Steering Committee Meeting, San Diego, CA, November 2000
23. Macallum GE, Houston BJ: Characterization of cardiac alterations in nonsedated cynomolgus monkeys. Am J Vet Res 54:327, 1993
24. Van de Water A, Verheyen J, Xhonneux R, et al: An improved method to correct the QT interval of the electrocardiogram for changes in heart rate. J Pharmacol Methods 22:207, 1989
25. Drici MD, Clement N: Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome. Drug Saf 24:575, 2001